Shizao Wan (十枣丸)十枣丸
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 上海雷允上封浜制药有限公司Chinese legal name: 上海雷允上封浜制药有限公司
主要成分Active Ingredients
- 甘遂(制Gansui Zhi
- 京大戟Jingda Ji
- 芫花(制Yuanhua Zhi
- 大枣(墨枣Dazao Mozao
药物知识说明
甘遂(制是一种在国家药监局注册认定的药品。标注生产企业为上海雷允上封浜制药有限公司。
该药品暂无关联的活性成分信息。
该药品标注的生产企业为：上海雷允上封浜制药有限公司Chinese legal name: 上海雷允上封浜制药有限公司、上海雷允上封浜制药有限公司Chinese legal name: 上海雷允上封浜制药有限公司、上海雷允上封浜制药有限公司Chinese legal name: 上海雷允上封浜制药有限公司。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 十枣丸) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 上海雷允上封浜制药有限公司.
No active ingredient relationships are currently recorded for this product in MedicineGraph.
Manufacturers recorded for this product: 上海雷允上封浜制药有限公司Chinese legal name: 上海雷允上封浜制药有限公司, 上海雷允上封浜制药有限公司Chinese legal name: 上海雷允上封浜制药有限公司, 上海雷允上封浜制药有限公司Chinese legal name: 上海雷允上封浜制药有限公司.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 十枣丸Recorded Chinese name: 十枣丸
- 剂型Dosage form: 丸剂Pills
- 规格Specification: 每50粒重约3gRecorded Chinese specification
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 上海雷允上封浜制药有限公司Chinese legal name: 上海雷允上封浜制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字Z31020257
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字Z31020257
Manufacturer
Chinese legal name: 上海雷允上封浜制药有限公司 (domestically manufactured)
Traditional functions
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字Z31020257
生产企业
上海雷允上封浜制药有限公司(国产)
功能主治
攻逐水饮。用于水饮积滞，腹水肿胀，胁下疼痛，喘逆气急。
用法用量
口服，一次3g，一日1～2次；或遵医嘱。
不良反应
尚不明确。
禁忌
1.体虚者及孕妇、年老体弱者忌服。
2.忌食盐，勿与甘草同服。
注意事项
1.得快利后应止服药,以糜粥自养。
2.应用本品时，须注意患者体质情况，若体虚邪实不胜攻逐者，可与健脾补益之剂交替使用，或先攻后补，或先补后攻。
贮藏
密封，置阴凉处。
规格
每50粒重约3g
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.